Nolato AB (publ) (LON:0OA9)

London flag London · Delayed Price · Currency is GBP · Price in SEK
56.15
-0.65 (-1.14%)
At close: May 23, 2025
-7.80%
Market Cap 1.22B
Revenue (ttm) 746.01M
Net Income (ttm) 53.59M
Shares Out n/a
EPS (ttm) 0.20
PE Ratio 22.80
Forward PE 20.55
Dividend 0.12 (0.21%)
Ex-Dividend Date May 7, 2025
Volume 14,805
Average Volume 38,497
Open 55.70
Previous Close 56.80
Day's Range 55.60 - 56.35
52-Week Range 48.04 - 64.70
Beta 0.91
RSI 48.86
Earnings Date May 6, 2025

About Nolato AB

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Sweden, Hungary, Asia, Europe, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste under the Compatherm brand; TreffLab by Nolato that in... [Read more]

Industry Miscellaneous Plastics Products
Founded 1938
Employees 5,837
Stock Exchange London Stock Exchange
Ticker Symbol 0OA9
Full Company Profile

Financial Performance

In 2024, Nolato AB's revenue was 9.66 billion, an increase of 1.24% compared to the previous year's 9.55 billion. Earnings were 658.00 million, an increase of 51.26%.

Financial numbers in SEK Financial Statements

News

Nolato AB (STU:NBF) Q4 2024 Earnings Call Highlights: Strong Profit Growth Amid Sector Challenges

Nolato AB (STU:NBF) Q4 2024 Earnings Call Highlights: Strong Profit Growth Amid Sector Challenges

3 months ago - GuruFocus

Q4 2024 Nolato AB Earnings Call Transcript

Q4 2024 Nolato AB Earnings Call Transcript

3 months ago - GuruFocus

Cyclical Industrials' Turnaround Is Close, Though Nolato Isn't Cheap, It's Still A Buy

Nolato is a Swedish polymer business with a focus on medical, integrated, and industrial solutions. The company's net cash position insulates it from debt risks, but it faces cyclicality risks in some...

1 year ago - Seeking Alpha